Interestingly, hallmarks related to hormone receptor signaling (i.e., early estrogen response genes: P = 0.012; late estrogen response genes: P = 0.002; and androgen response genes: P = 0.003) are also enriched amongst genes overexpressed in the primary tumor sample. This evidence concerns the gene NR4A1 and neoplasm.